Apremilast Promising for Plaque Psoriasis
Risankizumab & Apremilast Come to Market in Canada
Risankizumab Demonstrates Superiority to Secukinumab for Plaque Psoriasis
Imagining a Life Free from the Pain of Ankylosing Spondylitis
FDA Approves Risankizumab, Adds Stronger Warning to Sleep Medications
IV Meloxicam Stalls at FDA; Plus Health Canada Approves Risankizumab for Plaque Psoriasis
Health Canada Approves Certolizumab Pegol & NICE Issues Guidance for Certolizumab Pegol
Mirikizumab Promising for Plaque Psoriasis
FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review
- 1
- 2
- 3
- …
- 5
- Next Page »